跳至主要内容
临床试验/IRCT20220111053692N13
IRCT20220111053692N13已完成Unknown

Bioequivalence study of Tablet Ibuprofen ER 800 mg kimiara Heram pharmaceutical company versus Brufen® Retard Abbott/UK pharmaceutical company Tablet after single oral dosing in healthy volunteers

Kimiara Heram Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
Male

入选标准

  • 18 to 55 years old
  • Weight in range of 10 % proper body weight
  • All volunteers should be in a good health condition on the basis of medical history ,physical examination , routine blood test.
  • Possessing negative test for hepatitis B surface antigen (HBs-Ag), Antihepatitis-C antibody (anti-HCV) and anti-HIV.
  • Gender: male

排除标准

  • Any history of allergy to the drug or formulation components
  • Those with known history of drug abuse. alcohol consumer or cigarette smokers.
  • Taking medications that have drug interactions with Ibuprofen until one month before studying.
  • Disinclination to take the test
  • Blood donation or blood loss of more than 200 ml in the past month

研究者

发起方
Kimiara Heram Pharmaceutical Company

相似试验

Bioequivalence study of Ibuprofen ER 800 mg | 临床试验